Tech Company Financing Transactions
Silk Therapeutics Funding Round
On 3/26/2015, Silk Therapeutics announced $2 million in Series A investment from The Kraft Group.
Transaction Overview
Company Name
Announced On
3/26/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
The Kraft Group (Lead Investor) (Daniel Kraft)
Proceeds Purpose
Silk Therapeutics will apply this new capital to support the launch of its clean, luxurious skincare line with initial rollout in the northeast and expanded efforts nationally, as well as to market the company's professional line to the med-derm and spa communities.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
196 Boston Ave. 1100
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
The founders of Silk Therapeutics are world-renowned for pioneering silk science to improve human health. Dr. Greg Altman (CEO) and Dr. Rebecca Horan (COO) have worked together for more than 15 years developing silk-based applications, and now addressing unmet needs in skincare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Altman
Chief Operating Officer
Rebecca Horan
Browse more venture capital transactions:
Prev: 3/26/2015: ChowNow venture capital transaction
Next: 3/26/2015: BetterCloud venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs